These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

116 related articles for article (PubMed ID: 9711248)

  • 1. The synthesis and antifungal activity of N-alkylated analogs of echinocandin B.
    Jamison JA; Zeckner DJ; Rodriguez MJ
    J Antibiot (Tokyo); 1997 Jul; 50(7):562-6. PubMed ID: 9711248
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Semisynthetic chemical modification of the antifungal lipopeptide echinocandin B (ECB): structure-activity studies of the lipophilic and geometric parameters of polyarylated acyl analogs of ECB.
    Debono M; Turner WW; LaGrandeur L; Burkhardt FJ; Nissen JS; Nichols KK; Rodriguez MJ; Zweifel MJ; Zeckner DJ; Gordee RS
    J Med Chem; 1995 Aug; 38(17):3271-81. PubMed ID: 7650681
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Total synthesis and antifungal evaluation of cyclic aminohexapeptides.
    Klein LL; Li L; Chen HJ; Curty CB; DeGoey DA; Grampovnik DJ; Leone CL; Thomas SA; Yeung CM; Funk KW; Kishore V; Lundell EO; Wodka D; Meulbroek JA; Alder JD; Nilius AM; Lartey PA; Plattner JJ
    Bioorg Med Chem; 2000 Jul; 8(7):1677-96. PubMed ID: 10976515
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Chemical diversity in lipopeptide antifungal antibiotics.
    Hino M; Fujie A; Iwamoto T; Hori Y; Hashimoto M; Tsurumi Y; Sakamoto K; Takase S; Hashimoto S
    J Ind Microbiol Biotechnol; 2001 Sep; 27(3):157-62. PubMed ID: 11780786
    [TBL] [Abstract][Full Text] [Related]  

  • 5. FR131535, a novel water-soluble echinocandin-like lipopeptide: synthesis and biological properties.
    Fujie A; Iwamoto T; Sato B; Muramatsu H; Kasahara C; Furuta T; Hori Y; Hino M; Hashimoto S
    Bioorg Med Chem Lett; 2001 Feb; 11(3):399-402. PubMed ID: 11212120
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The synthesis of water soluble prodrugs analogs of echinocandin B.
    Rodriguez MJ; Vasudevan V; Jamison JA; Borromeo PS; Turner WW
    Bioorg Med Chem Lett; 1999 Jul; 9(13):1863-8. PubMed ID: 10406656
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Synthesis of new analogs of echinocandin B by enzymatic deacylation and chemical reacylation of the echinocandin B peptide: synthesis of the antifungal agent cilofungin (LY121019).
    Debono M; Abbott BJ; Fukuda DS; Barnhart M; Willard KE; Molloy RM; Michel KH; Turner JR; Butler TF; Hunt AH
    J Antibiot (Tokyo); 1989 Mar; 42(3):389-97. PubMed ID: 2708132
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Synthesis and evaluation of LY121019, a member of a series of semisynthetic analogues of the antifungal lipopeptide echinocandin B.
    Debono M; Abbott BJ; Turner JR; Howard LC; Gordee RS; Hunt AS; Barnhart M; Molloy RM; Willard KE; Fukuda D
    Ann N Y Acad Sci; 1988; 544():152-67. PubMed ID: 3063167
    [No Abstract]   [Full Text] [Related]  

  • 9. The synthesis and antifungal activity of nitrogen containing hemiaminal ethers of LY303366.
    Jamison JA; LaGrandeur LM; Rodriguez MJ; Turner WW; Zeckner DJ
    J Antibiot (Tokyo); 1998 Feb; 51(2):239-42. PubMed ID: 9544949
    [No Abstract]   [Full Text] [Related]  

  • 10. Synthesis, stability, and biological evaluation of water-soluble prodrugs of a new echinocandin lipopeptide. Discovery of a potential clinical agent for the treatment of systemic candidiasis and Pneumocystis carinii pneumonia (PCP).
    Balkovec JM; Black RM; Hammond ML; Heck JV; Zambias RA; Abruzzo G; Bartizal K; Kropp H; Trainor C; Schwartz RE
    J Med Chem; 1992 Jan; 35(1):194-8. PubMed ID: 1732529
    [No Abstract]   [Full Text] [Related]  

  • 11. Novel echinocandin antifungals. Part 1: novel side-chain analogs of the natural product FR901379.
    Tomishima M; Ohki H; Yamada A; Maki K; Ikeda F
    Bioorg Med Chem Lett; 2008 Feb; 18(4):1474-7. PubMed ID: 18207736
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Echinocandins and pneumocandins--a new antifungal class with a novel mode of action.
    Denning DW
    J Antimicrob Chemother; 1997 Nov; 40(5):611-4. PubMed ID: 9421307
    [No Abstract]   [Full Text] [Related]  

  • 13. From natural products to clinically useful antifungals.
    Barrett D
    Biochim Biophys Acta; 2002 Jul; 1587(2-3):224-33. PubMed ID: 12084464
    [TBL] [Abstract][Full Text] [Related]  

  • 14. FK463, a novel water-soluble echinocandin lipopeptide: synthesis and antifungal activity.
    Tomishima M; Ohki H; Yamada A; Takasugi H; Maki K; Tawara S; Tanaka H
    J Antibiot (Tokyo); 1999 Jul; 52(7):674-6. PubMed ID: 10513849
    [No Abstract]   [Full Text] [Related]  

  • 15. Structure-Activity Relationships of a Series of Echinocandins and the Discovery of CD101, a Highly Stable and Soluble Echinocandin with Distinctive Pharmacokinetic Properties.
    James KD; Laudeman CP; Malkar NB; Krishnan R; Polowy K
    Antimicrob Agents Chemother; 2017 Feb; 61(2):. PubMed ID: 27919891
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Deoxymulundocandin--a new echinocandin type antifungal antibiotic.
    Mukhopadhyay T; Roy K; Bhat RG; Sawant SN; Blumbach J; Ganguli BN; Fehlhaber HW; Kogler H
    J Antibiot (Tokyo); 1992 May; 45(5):618-23. PubMed ID: 1624363
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pneumocandin D0, a new antifungal agent and potent inhibitor of Pneumocystis carinii.
    Morris SA; Schwartz RE; Sesin DF; Masurekar P; Hallada TC; Schmatz DM; Bartizal K; Hensens OD; Zink DL
    J Antibiot (Tokyo); 1994 Jul; 47(7):755-64. PubMed ID: 8071120
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Determination of the relative and absolute configuration of the dimethylmyristoyl side chain of pneumocandin B0 by asymmetric synthesis.
    Leonard WR; Belyk KM; Bender DR; Conlon DA; Hughes DL; Reider PJ
    Org Lett; 2002 Nov; 4(24):4201-4. PubMed ID: 12443058
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Design, synthesis and antimicrobial properties of non-hemolytic cationic alpha-cyclopeptoids.
    Comegna D; Benincasa M; Gennaro R; Izzo I; De Riccardis F
    Bioorg Med Chem; 2010 Mar; 18(5):2010-8. PubMed ID: 20153656
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Enzymatic deacylation of teicoplanin followed by reductive alkylation: synthesis and antibacterial activity of new glycopeptides.
    Snyder NJ; Cooper RD; Briggs BS; Zmijewski M; Mullen DL; Kaiser RE; Nicas TI
    J Antibiot (Tokyo); 1998 Oct; 51(10):945-51. PubMed ID: 9917008
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.